CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...